Sun Pharmaceutical Industries Limited (BOM: 524715)
India flag India · Delayed Price · Currency is INR
1,861.70
+20.20 (1.10%)
At close: Dec 27, 2024

Sun Pharmaceutical Industries Company Description

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally.

The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas.

It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and antiretrovirals medications, as well as over-the-counter products.

The company was founded in 1983 and is headquartered in Mumbai, India.

Sun Pharmaceutical Industries Limited
Country India
Founded 1983
Industry Pharmaceutical Preparations
Employees 43,000
CEO Dilip Shanghvi

Contact Details

Address:
Sun House
Mumbai, Gujarat 400063
India
Phone 91 22 4324 4324
Website sunpharma.com

Stock Details

Ticker Symbol 524715
Exchange Bombay Stock Exchange
Fiscal Year April - March
Reporting Currency INR
SIC Code 2834

Key Executives

Name Position
Dilip Shanghvi Chief Executive Officer
C. Muralidharan Chief Financial Officer
Davinder Singh Chief Operating Officer
Abhishek Sharma Head of Investor Relations